DAMCAPITAL

Q2 FY27 Consolidated Revenue ₹54.24Cr vs ₹107.05Cr (▼49% YoY) EBITDA ₹24.45Cr vs ₹75.90Cr (▼68% YoY) PAT ₹13.54Cr vs ₹52.15Cr (▼74% YoY) EBITDA Margin 45% vs 71% (▼2582bps)

Q2 FY27 Consolidated Revenue ₹54.24 Cr vs ₹107.05 Cr (▼49.3% YoY) EBITDA ₹24.45 Cr vs ₹75.90 Cr (▼67.8% YoY) PAT ₹13.54 Cr vs ₹52.15 Cr (▼74.0% YoY) EBITDA Margin 45.08% vs 70.90% (▼2582bps)

- Q2 FY27 Total Income stood at ₹54.3 Cr (up 81% QoQ) and PAT at ₹13.5 Cr. - Executed 8 ECM transactions in Q2 FY27 raising over ₹30,500 Cr. - Pipeline includes 19 IPOs across sectors, with 3 new IPOs added during the quarter. - Available net cash stood at ₹314 Cr as of September 30, 2026.

- Q2 FY27 Total Income reached ₹54.3 Cr vs ₹107.1 Cr in Q2 FY26; PAT stood at ₹13.5 Cr vs ₹52.2 Cr YoY. - Executed 8 ECM transactions raising over ₹30,500 Cr; maintains a pipeline of 19 IPO mandates. - Net cash available stood at ₹314 Cr as of September 30, 2026.

Q2 FY27 Consolidated Revenue ₹54.24Cr vs ₹107.05Cr (▼49.3% YoY) EBITDA ₹24.45Cr vs ₹75.90Cr (▼67.8% YoY) PAT ₹13.54Cr vs ₹52.15Cr (▼74.0% YoY) EBITDA Margin 45.08% vs 70.90% (▼2582bps)

- DAM Capital Advisors Limited has submitted the registered Trust Deed of 'DAM Capital ESOP Trust' pursuant to Regulation 3(3) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. - The trust has been set up as an irrevocable employee welfare trust for the administration and implementation of the ratified and amended DAM Capital Employees Stock Option Scheme 2024. - The initial corpus of the trust is fixed at Rs. 10,000, and the trust is established with the objective of attracting, retaining, and incentivizing employees.

- Trading window closed effective Thursday, October 1, 2026. - Closure relates to approval of Q2 and H1 FY27 unaudited financial results for the period ending September 30, 2026. - The trading window will reopen 48 hours after the declaration of results.

- DAM Capital Advisors Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 on August 13, 2026. This report forms part of the Company's Annual Report. Its corporate policies cover principles of responsible business conduct. The report also noted a substantial decline in shareholder complaints during FY 2025-26.

- Record Date for final dividend payment fixed as Friday, August 28, 2026. - Payment of dividend will be made within 30 days from the date of Annual General Meeting, subject to approval.

- Q1 FY27 Consolidated Revenue ₹29.97 Cr vs ₹30.88 Cr (▼3% YoY) - EBITDA ₹5.95 Cr vs ₹6.03 Cr (▼1% YoY) - PAT ₹0.15 Cr vs ₹0.23 Cr (▼35% YoY) - EBITDA Margin 19.85% vs 19.53% (▲32bps) - The Board approved the appointment of Mr. Dhvanil Sanjiv Dharia as Additional Director and Whole Time Director for a period of 5 years. - Mr. Natarajan Srinivasan, Independent Director, will complete his tenure and cease to be a Director on August 18, 2026. - Mr. Jateen Madhukar Doshi ceased to be a Whole Time Director and KMP on June 9, 2026, upon completion of his term. - The 33rd Annual General Meeting is scheduled for Tuesday, September 8, 2026.

- Q1 FY27 Consolidated Operating Revenue ₹29.86Cr vs ₹30.85Cr (▼3.21% YoY) - EBITDA ₹5.95Cr vs ₹6.03Cr (▼1.33% YoY) - PAT ₹0.15Cr vs ₹0.23Cr (▼34.78% YoY) - EBITDA Margin 19.93% vs 19.55% (▲38bps) - Board approved appointment of Mr. Dhvanil Sanjiv Dharia as Additional Director and Whole Time Director for 5 years. - Mr. Natarajan Srinivasan ceased to be an Independent Director upon completion of his tenure on August 18, 2026. - The 33rd Annual General Meeting will be held on September 8, 2026.

- Q1 FY27 Consolidated Revenue ₹29.86Cr vs ₹30.85Cr (▼3.21% YoY) - EBITDA ₹5.95Cr vs ₹6.03Cr (▼1.33% YoY) - PAT ₹0.15Cr vs ₹0.23Cr (▼34.78% YoY) - EBITDA Margin 19.92% vs 19.55% (▲37bps)

- Q1 FY27 Consolidated Total Income ₹30.0Cr vs ₹30.9Cr (▼2.9% YoY) - PAT ₹0.15Cr vs ₹0.23Cr (▼34.8% YoY)

- Q1 FY27 Total Income ₹30.0 Cr vs ₹30.9 Cr (▼2.9% YoY) - PAT ₹0.15 Cr vs ₹0.23 Cr (▼34.8% YoY) - PAT Margin 0.5% vs 0.8% (▼30bps)

- Q1 FY27 Consolidated Revenue ₹29.86Cr vs ₹30.85Cr (▼3.21% YoY) - EBITDA ₹5.95Cr vs ₹6.03Cr (▼1.33% YoY) - PAT ₹0.15Cr vs ₹0.23Cr (▼34.78% YoY) - EBITDA Margin 19.92% vs 19.55% (▲37bps) - Board approved the appointment of Mr. Dhvanil Sanjiv Dharia as Additional Director and Whole Time Director for 5 years. - Mr. Natarajan Srinivasan will cease to be an Independent Director upon completing his tenure on August 18, 2026. - The 33rd Annual General Meeting is scheduled for September 8, 2026.

- Intimation of Trading Window Closure for Designated Persons from July 1, 2026. - Closure for consideration and approval of Unaudited Standalone and Consolidated Financial Results for the quarter ending June 30, 2026. - The trading window will open 48 hours after the declaration of the said Financial Results. - The date of the Board Meeting will be intimated separately.